menu

Emerging Concepts in the Management of MS: A Focus on T and B-Cell Targeting

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Emerging Concepts in the Management of MS: A Focus on T and B-Cell Targeting

Professor Andrew Chan will provide you with his perspective on the role of T and B cells in treating patients with multiple sclerosis.
  • Overview

    Professor Andrew Chan, Chief Physician, Deputy Clinical Director, Head of the Outpatient Neuro Center, and Head of the Neurological Policlinic at the University Hospital of Bern in Bern, Switzerland, joins Dr. Matt Birnholz on this special edition of On the Frontlines of Multiple Sclerosis.  

    Professor Chan will be discussing the role of T and B cells in treating patients with multiple sclerosis, specifically when to employ these treatment techniques, the risks associated, and what is on the horizon for T and B cell research.

    This program has been brought to you through an independent educational grant from Merck KGaA, Darmstadt, Germany.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.